| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |